Aurobindo Pharma approves appointment of chairman

27 Aug 2012 Evaluate
Aurobindo Pharma has informed that the board of directors of the company at its meeting held on August 25, 2012, have approved the proposal of appointment of P. V. Ramprasad Reddy as executive chairman of Aurobindo Pharma USA, Inc., the wholly owned subsidiary of the company with effect from December 01, 2012. The said proposal is subject to further approval of the shareholders of the company. Accordingly, an extra ordinary general meeting of the company is being convened on September 27, 2012. 

Consequent to his proposed appointment in the company's US subsidiary, the board has also approved Ramprasad Reddy relinquishing the executive responsibilities as whole time director of the company and his continuation as a non-executive director of the company not liable to retire by rotation with effect from December 01, 2012.

The above information is a part of company's filings submitted to BSE.



Aurobindo Pharma Share Price

1172.50 1.10 (0.09%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×